- Home
- ZNTL vs NATR Comparison
ZNTL vs NATR Comparison
Compare ZNTL & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- NATR
- Stock Information
- Founded
- ZNTL 2014
- NATR 1972
- Country
- ZNTL United States
- NATR United States
- Employees
- ZNTL N/A
- NATR N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- NATR Biotechnology: Pharmaceutical Preparations
- Sector
- ZNTL Health Care
- NATR Health Care
- Exchange
- ZNTL Nasdaq
- NATR Nasdaq
- Market Cap
- ZNTL 238.2M
- NATR 254.1M
- IPO Year
- ZNTL 2020
- NATR N/A
- Fundamental
- Price
- ZNTL $3.12
- NATR $12.60
- Analyst Decision
- ZNTL Buy
- NATR Strong Buy
- Analyst Count
- ZNTL 7
- NATR 2
- Target Price
- ZNTL $10.86
- NATR $19.50
- AVG Volume (30 Days)
- ZNTL 1.2M
- NATR 23.4K
- Earning Date
- ZNTL 11-04-2024
- NATR 11-05-2024
- Dividend Yield
- ZNTL N/A
- NATR N/A
- EPS Growth
- ZNTL N/A
- NATR 191.23
- EPS
- ZNTL N/A
- NATR 0.79
- Revenue
- ZNTL $40,560,000.00
- NATR $441,682,000.00
- Revenue This Year
- ZNTL N/A
- NATR $0.59
- Revenue Next Year
- ZNTL N/A
- NATR $4.12
- P/E Ratio
- ZNTL N/A
- NATR $16.33
- Revenue Growth
- ZNTL N/A
- NATR 2.14
- 52 Week Low
- ZNTL $2.83
- NATR $10.81
- 52 Week High
- ZNTL $18.24
- NATR $21.72
- Technical
- Relative Strength Index (RSI)
- ZNTL 44.34
- NATR 37.67
- Support Level
- ZNTL $2.92
- NATR $12.85
- Resistance Level
- ZNTL $3.23
- NATR $13.49
- Average True Range (ATR)
- ZNTL 0.17
- NATR 0.38
- MACD
- ZNTL 0.00
- NATR -0.03
- Stochastic Oscillator
- ZNTL 38.33
- NATR 0.00
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.